I think an unfortunate result of the ACC meetings is the feeling that if a study is not released early and does not make the front page of the New York Times then it is not relevant or worth talking about. We’ll save …
Category: PrimeCuts
Clinical Correlations
ShortCuts: This Week in the Journals
April 16, 2007Overall, it seemed like a relatively quiet week in the news world. Winter weather perseveres, Larry Birkhead is the father, and Sanjaya is still singing (or trying to). A perusal of the week’s medicine journals, however, is somewhat uplifting as it …
ShortCuts-This Week in the Journals
April 9, 2007The April 3rd issue of the Annals provides guidelines for screening mammography in women age 40-49. In the article and an accompanying editorial, the authors suggest that in women younger than age 50, the possible modest benefit of routine mammography screening …
ShortCuts: This Week in the Journals
April 2, 2007JAMA reported on two important “negative” trials: The results of the EVEREST trial, comparing tolvaptan (a novel vasopressin V2 receptor blocker) to placebo for the treatment of acute CHF exacerbation, indicate that this agent had no effect …
ShortCuts-This Week in the Journals
March 26, 2007It seemed to be a slow week in the medical literature, but that will likely change as the 2007 American College of Cardiology Scientific Session is now underway. Theheart.org has an excellent summary about what to expect from the meetings. (free …
ShortCuts-This Week in the Journals
March 19, 2007Welcome to ShortCuts, yet another new feature of Clinical Correlations. Every week we will post what we feelare the 5 most interesting articles from the news and literature with links. We’re not attempting to digest any of this for you or to be …